ArticleFrontiers in oncology2021

Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond.

Michael Orth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.